Clinical Trial Update: Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cannabinoids combined with an anti-inflammatory diet for neuropathic pain after spinal cord injury; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Cannabinoids (cannabinoids)

Snippet

Sponsor: Eldon Loh, MD | Conditions: Spinal Cord Injuries, Neuropathic Pain | Phase 3 | Status: COMPLETED